⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL910459 | 1.00 | — | — | |
| SCHEMBL8159206 | 0.87 | — | — | |
| SCHEMBL8159203 | 0.87 | — | — | |
| SCHEMBL14861053 | 0.76 | — | — | |
| SCHEMBL6365838 | 0.67 | — | — | |
| SCHEMBL834791 | 0.67 | — | — | |
| SCHEMBL6365840 | 0.67 | — | — | |
| SCHEMBL834790 | 0.67 | — | — | |
| SCHEMBL79832 | 0.66 | — | — | |
| SCHEMBL9207872 | 0.66 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 73 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114432327-A | Application of flavonoid carbon glycoside compound in preparation of medicine for preventing or treating acute lung injury and/or acute respiratory distress syndrome | 苏州凯祥生物科技有限公司 | 2022-05-06 | — | — | CN | claimed |
| CN-106795174-B | Antiviral active diazacyclospirodiketopiperazine alkaloid derivative and preparation method thereof | 扬州蓝色生物医药科技有限公司 | 2020-04-28 | — | — | CN | claimed |
| EP-3108900-B1 | PROTOTYPE SYSTEMS OF THERANOSTIC BIOMARKERS FOR IN VIVO MOLECULAR MANAGEMENT OF CANCER | EPOS IASIS RES AND DEVELOPMENT LTD (CY) | 2019-04-24 | — | — | EP | claimed |
| US-9890187-B2 | Prototype systems of theranostic biomarkers for in vivo molecular management of cancer | EPOS-IASIS RESEARCH AND DEVELOPMENT, LTD. (CY) | 2018-02-13 | — | — | US | claimed |
| US-6110933-A | AN ENZYME INHIBITOR TREATING PANCREATITIS, HEPATITIS, CHRONIC RENAL FAILURE, ENDOTOXIN SHOCK, GRAM-NEGATIVE SEPTIC SHOCK, ARTHRITIS, RESPIRATORY DISEASE, HEART DISEASE, ALLERGIC DISEASE, THROMBOSIS, ARTERIOSCLEROSIS, PAIN | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2000-08-29 | — | — | US | claimed |
| JP-9059139-A | — | — | None | — | — | JP | disclosed |
| EP-3741865-B1 | NON-NATURAL MICROBIAL ORGANISMS WITH IMPROVED ENERGETIC EFFICIENCY | GENOMATICA INC (US) | 2024-03-13 | — | — | EP | disclosed |
| CN-111825631-B | BE-43547 derivative and salt thereof, preparation method and application thereof in preparation of anticancer drugs | 新沂尚德药缘药业有限公司 | 2023-10-13 | — | — | CN | disclosed |
| US-20230287464-A1 | MICROORGANISMS AND METHODS FOR THE PRODUCTION OF BUTADIENE USING ACETYL-COA | GENOMATICA INC (US) | 2023-09-14 | — | — | US | disclosed |
| US-20230126921-A1 | NON-NATURAL MICROBIAL ORGANISMS WITH IMPROVED ENERGETIC EFFICIENCY | AGAIN BIO APS (DK) | 2023-04-27 | — | — | US | disclosed |
| US-11371063-B2 | Microorganisms and methods for the production of butadiene using acetyl-coA | GENOMATICA, INC. (US) | 2022-06-28 | — | — | US | disclosed |
| CN-114432327-A | Application of flavonoid carbon glycoside compound in preparation of medicine for preventing or treating acute lung injury and/or acute respiratory distress syndrome | 苏州凯祥生物科技有限公司 | 2022-05-06 | — | — | CN | disclosed |
| EP-0906115-A1 | COMBINED USE OF GnRH AGONIST AND ANTAGONIST | Takeda Chemical Industries, Ltd. (JP) | 1999-04-07 | — | — | EP | disclosed |
| EP-0854863-A1 | ESTERS AND AMIDES AS PLA2 INHIBITORS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1998-07-29 | — | — | EP | disclosed |
| WO-1997040846-A1 | COMBINED USE OF GnRH AGONIST AND ANTAGONIST | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1997-11-06 | — | — | WO | disclosed |
| EP-0781774-A2 | Prolactin production inhibitory agents | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1997-07-02 | — | — | EP | disclosed |
| JP-H0959139-A | PENTADIENOYL DERIVATIVE AND ULTRAVIOLET RAY ABSORBER | NISSIN FOOD PROD CO LTD | 1997-03-04 | — | — | JP | disclosed |
| WO-1997003951-A1 | ESTERS AND AMIDES AS PLA2 INHIBITORS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1997-02-06 | — | — | WO | disclosed |
| EP-0741697-A1 | AMINO ACID DERIVATIVES AND THEIR USE AS PHOSPHOLIPASE A2 INHIBITORS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1996-11-13 | — | — | EP | disclosed |
| WO-1995019959-A1 | AMINO ACID DERIVATIVES AND THEIR USE AS PHOSPHOLIPASE A2 INHIBITORS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1995-07-27 | — | — | WO | disclosed |